..from the 8-k February 22nd, talking about the IRB approval ~ which from what I've read, is HUGE!!
Dr. Yehuda Baruch, the Company's Director of Research and Regulatory Affairs, stated "This approval is a significant milestone for OWC, where our mission is to bring the same rigorous approach common to traditional pharmaceutical development to the medical cannabis field. As we reported earlier, the results of our efficacy studies were so encouraging that management decided to extend the size and scope of the study to verify the biological markers that had been generated to date, among other things. "
Every time that wheel turns round, bound to cover just a little more ground..
Bob Hunter